EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Human CD34+ hematopoietic stem cell hierarchy: how far are we with its delineation at the most primitive level?

Fernando Anjos-Afonso iD, Dominique Bonnet iD

Blood · 10.08.2023 · 142 (6) · 509-518

DOI: 10.1182/blood.2022018071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, erschienen am 10.08.2023. Verfasst von Fernando Anjos-Afonso und 1 weiteren Autor:innen. Beteiligte Einrichtung: Haematopoietic Signalling Group, European Cancer Stem Cell Institute, School of Biosciences, Cardiff University, Cardiff, United Kingdom. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Wellcome Trust, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ability to isolate and characterize different hematopoietic stem cell (HSC) or progenitor cell populations opens avenues to understand how hematopoiesis is regulated during development, homeostasis, and regeneration as well as in age-related conditions such as clonal hematopoiesis and leukemogenesis. Significant progress has been made in the past few decades in determining the composition of the cell types that exist in this system, but the most significant advances have come from mouse studies. However, recent breakthroughs have made significant strides that have enhanced the resolution of the human primitive hematopoietic compartment. Therefore, we aim to review this subject not only from a historical perspective but also to discuss the progress made in the characterization of the human postnatal CD34+ HSC–enriched populations. This approach will enable us to shed light on the potential future translational applicability of human HSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationLeukemiaHumansMiceAnimalsHematopoietic Stem CellsAntigens, CD34Hematopoiesis

Substanzen

Antigens, CD34

Autor:innen und Institutionen

  • Haematopoietic Signalling Group, European Cancer Stem Cell Institute, School of Biosciences, Cardiff University, Cardiff, United Kingdom.
  • Haematopoietic Stem Cell Laboratory, Francis Crick Institute, London, United Kingdom.

ORCID-Profile: Fernando Anjos-Afonso, Dominique Bonnet

Förderung

  • Biotechnology and Biological Sciences Research Council
  • Wellcome Trust
  • Medical Research Council
  • Cancer Research UK

Zitieren

APA

Anjos-Afonso, F., & Bonnet, D. (2023). Human CD34+ hematopoietic stem cell hierarchy: how far are we with its delineation at the most primitive level?. Blood, 142(6), 509-518. https://doi.org/10.1182/blood.2022018071

Vancouver

Anjos-Afonso F, Bonnet D. Human CD34+ hematopoietic stem cell hierarchy: how far are we with its delineation at the most primitive level?. Blood. 2023;142(6):509-518. doi:10.1182/blood.2022018071

BibTeX
@article{AnjosAfonso2023,
  author = {Anjos-Afonso, Fernando and Bonnet, Dominique},
  title = {Human CD34+ hematopoietic stem cell hierarchy: how far are we with its delineation at the most primitive level?},
  journal = {Blood},
  year = {2023},
  volume = {142},
  number = {6},
  pages = {509--518},
  doi = {10.1182/blood.2022018071}
}
Kostenlos starten →